Cargando…
Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer
Pancreatic cancer is the eighth leading cause of cancer-related deaths worldwide. Chemotherapy including gemcitabine, 5-fluorouracil, adriamycin and cisplatin, immunotherapy with immune checkpoint inhibitors and targeted therapy have been demonstrated to significantly improve prognosis of pancreatic...
Autores principales: | Wei, Ling, Sun, Jujie, Wang, Xingwu, Huang, Yizhou, Huang, Linying, Han, Linyu, Zheng, Yanxiu, Xu, Yuan, Zhang, Nasha, Yang, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407809/ https://www.ncbi.nlm.nih.gov/pubmed/37560164 http://dx.doi.org/10.3389/fcell.2023.1226639 |
Ejemplares similares
-
Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer
por: Wei, Ling, et al.
Publicado: (2021) -
Noncoding RNAs in gastric cancer: implications for drug resistance
por: Wei, Ling, et al.
Publicado: (2020) -
Emerging Roles of Long Noncoding RNAs in Immuno-Oncology
por: Wang, Xin, et al.
Publicado: (2021) -
Noncoding RNAs in Drug Resistance of Gastrointestinal Stromal Tumor
por: Li, Jiehan, et al.
Publicado: (2022) -
Emerging Roles of Long Noncoding RNAs in Breast Cancer Epigenetics and Epitranscriptomics
por: Wanowska, Elżbieta, et al.
Publicado: (2022)